The companies BridgeBio, Erasca, Chai Discovery, and MeiraGTx bagged the biggest biotech funding rounds overall in July 2026.
We look at some of the top companies that are investigating CAR-T therapies in clinical trials for autoimmune diseases.
Delve into what Merck has planned for the future of its pipeline as Keytruda's patent is getting closer to expiry.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results